Rosetta Genomics(OTC) ROSGQ

Market Cap$600.00

Since IPO (2007)-100%

5 Year-100%

1 Year+0%

1 Month+9,900%

$0.00

+0.00%

+0.00Today

Rosetta Genomics last closing stock price
Metric	Price	Date
Last close	USD 0.00	2026-08-03

Rosetta Genomics stock price return by period
Period	Price return	Price at period start	Period start date
1 week	+0%	USD 0.00	2026-07-06
1 month	+9,900%	USD 0.00	2026-07-02
3 month	+0%	USD 0.00	2026-04-13
Year to date	+9,900%	USD 0.00	2025-12-24
1 year	+0%	USD 0.00	2025-07-25
3 year	+0%	USD 0.00	2023-08-02
5 year	-99.75%	USD 0.04	2021-08-04
Since inception	-100%	USD 5,270.41	2007-02-27

Rosetta Genomics Financials at a Glance

Market Cap

$600.00

Revenue (TTM)

$5.49M

Net Income (TTM)

-$14.27M

EPS (TTM)

$0.00

P/E Ratio

0.00

Dividend

$0.00

Beta (Volatility)

-22.62 (Low)

Dividend

$0.00

Beta (Volatility)

-22.62 (Low)

Price

$0.00

Volume

Open

$0.00

Price

$0.00

Volume

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

Dec 18, 2024

Dividend

$0.00

Beta (Volatility)

-22.62 (Low)

Price

$0.00

Volume

Open

$0.00

Previous Close

$0.00

Daily Range

$0.00 - $0.00

52-Week Range

$0.00 - $0.00

Estimated Earnings Date

Dec 18, 2024

ROSGQ News

No articles available.

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Rosetta Genomics

Rosetta Genomics Ltd. is a global leader in genomic diagnostics, specializing in innovative microRNA technologies. The company offers a diverse range of diagnostic assays aimed at improving patient care in oncology and other medical fields.

Products and Services

RosettaGX Cancer Origin for identifying metastatic cancer sources
mi-KIDNEY for classifying kidney tumors from pathology samples
UroVysion, a urine-based FISH assay for bladder cancer detection

Growth Outlook

Collaborative partnership with Meir Medical Center to develop microRNA classifiers
Expansion of diagnostic offerings in oncology and urology markets
Potential for increased adoption of microRNA technologies in clinical settings

Financial Highlights

Recent quarterly revenue of $870,000, showing growth potential
Current ratio of 2.50 indicates strong liquidity position
Cash and cash equivalents of $1,325,000 support ongoing operations

Rosetta Genomics Ltd. is positioned in the medical diagnostics and research industry, focusing on advanced genomic solutions. The company’s proprietary technologies are designed to enhance diagnostic accuracy and patient outcomes. With a strong emphasis on research and development, Rosetta Genomics aims to expand its product portfolio and market reach. The recent financial data indicates a solid liquidity position, which may facilitate further growth initiatives. The ongoing collaborations and partnerships are expected to drive innovation and enhance the company's competitive edge in the rapidly evolving healthcare landscape.

AI Generated • Aug 1, 2026

Industry

Biotechnology

Sector

Health Care

Headquarters

Rehovot, TA 76706, IL

ROSGQ Financials

Key Financial Metrics (TTM)

Gross Margin

19.44%

Operating Margin

-169.63%

Net Income Margin

-175.80%

Return on Equity

-135.07%

Return on Capital

-190.75%

Return on Assets

-135.72%

Earnings Yield

N/A

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$600.00

Shares Outstanding

5.93M

Volume

Avg. Volume

8.46

Financials (TTM)

Gross Profit

$636.00K

Operating Income

-$12.90M

EBITDA

-$13.46M

Operating Cash Flow

-$20.03M

Capital Expenditure

$0.00

Free Cash Flow

-$21.04M

Cash & ST Invst.

$1.33M

Total Debt

$2.45M

Rosetta Genomics Performance Analysis

Rosetta Genomics sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q2	2016-06-30	-84.5%
Q3	2016-09-30	444.6%
Q4	2016-12-31	-8.2%
Q2	2017-06-30	N/A

Rosetta Genomics sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q2	2016-06-30	18.8%
Q3	2016-09-30	-16.9%
Q4	2016-12-31	-21.9%
Q2	2017-06-30	N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Currently no data to display.

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Currently no data to display.

Quarterly Performance

Name

Q2 2017YOY CHG

Revenue

$870.00K

-66.6%

Gross Profit

$301.00K

-68.1%

Gross Margin

34.60%

N/A

Market Cap

$600.00

N/A

Market Cap/Employee

$6.98

N/A

Employees

N/A

Net Income

-$2.07M

+48.7%

EBITDA

-$1.37M

+65.8%

Quarterly Fundamentals

Name

Q2 2017YOY CHG

Total Cash

$1.33M

-88.9%

Total Debt

$2.45M

N/A

Accounts Receivable

$987.00K

-74.1%

Inventory

$0.00

N/A

Long Term Debt

$2.43M

N/A

Short Term Debt

$110.00K

N/A

Return on Assets

-1.36%

N/A

Return on Invested Capital

-1.92%

N/A

Free Cash Flow

-$12.26M

N/A

Operating Cash Flow

-$11.96M

N/A

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

SIGOSunset Island Group, Inc.

SIGOSunset Island Group, Inc.$0.00+0.00%

MOTSMotus GI Holdings, Inc.

MOTSMotus GI Holdings, Inc.$0.00+0.00%

LGBICannabiz Mobile, Inc.

LGBICannabiz Mobile, Inc.$0.00+0.00%

OTRKQOntrak, Inc.

OTRKQOntrak, Inc.$0.00+0.00%

ATRXAdhera Therapeutics Inc

ATRXAdhera Therapeutics Inc$0.00+0.00%

HRALHear AtLast Holdings, Inc.

HRALHear AtLast Holdings, Inc.$0.00+0.00%

BIOCQBiocept, Inc.

BIOCQBiocept, Inc.$0.00+0.00%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

BITOProShares Trust - ProShares Bitcoin ETF

BITOProShares Trust - ProShares Bitcoin ETF$9.81+0.06%

SPCXSpace Exploration Technologies

SPCXSpace Exploration Technologies$134.00-0.04%

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF$8.88-0.03%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$41.20+0.06%

MRNAModerna

MRNAModerna$133.32-0.24%

NVDANvidia

NVDANvidia$216.85-0.00%

ETHAiShares Ethereum Trust - iShares Ethereum Trust ETF

ETHAiShares Ethereum Trust - iShares Ethereum Trust ETF$17.55+0.11%

Questions About ROSGQ

What is the current price of Rosetta Genomics?

Rosetta Genomics is trading at $0.00 per share.

What is the 52-week range for Rosetta Genomics?

Over the past 52 weeks, Rosetta Genomics has traded between $0.00 and $0.00.

How much debt does Rosetta Genomics have?

Rosetta Genomics total debt is unavailable.

How much cash does Rosetta Genomics have on hand?

Rosetta Genomics does not have cash on hand data available.

What is Rosetta Genomics’s dividend yield?

Rosetta Genomics does not currently have a dividend yield.

Rosetta Genomics(OTC) ROSGQ

Rosetta Genomics Financials at a Glance

ROSGQ News

Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About Rosetta Genomics

ROSGQ Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

Rosetta Genomics Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About ROSGQ

What is the current price of Rosetta Genomics?

What is the 52-week range for Rosetta Genomics?

How much debt does Rosetta Genomics have?

How much cash does Rosetta Genomics have on hand?

What is Rosetta Genomics’s dividend yield?

Premium Investing Services